The Gut-Brain Axis: How Your Microbiome Controls Your Mood, Focus & Longevity

There is a system in your body that produces the majority of your serotonin, manufactures GABA and dopamine precursors, regulates systemic inflammation, trains your immune system, and communicates directly with your brain through a dedicated nerve highway — all without you being aware of it. That system is your gut. Specifically, the trillions of microorganisms that live in it, and the bidirectional communication network they use to talk to your central nervous system. Scientists call this the gut-brain axis. It may be the most important biological system that mainstream medicine still largely ignores.

If you’ve read our piece on the gut-serotonin connection, you already know that 90–95% of your body’s serotonin is manufactured in your intestines. This article goes wider. Serotonin is one neurotransmitter. The gut-brain axis is the entire operating system — the vagus nerve, the enteric nervous system, the immune-inflammatory interface, the microbial metabolite signaling, and the endocrine crosstalk that together determine how you think, feel, focus, and age.

This is not alternative medicine. The gut-brain axis is one of the most actively researched areas in neuroscience, immunology, and gastroenterology. What follows is a comprehensive, science-first breakdown of what it is, how it works, what disrupts it, and — most importantly — what you can actually do about it.

The Vagus Nerve: Your Body’s Information Highway

The vagus nerve is the longest cranial nerve in the human body. It originates in the brainstem and extends all the way down through the chest and into the abdomen, innervating the heart, lungs, and virtually the entire gastrointestinal tract. Its name comes from the Latin vagus, meaning “wandering” — and it wanders far.

What makes the vagus nerve extraordinary in the context of the gut-brain axis is the direction of its traffic. Approximately 80–90% of vagal nerve fibers are afferent — meaning they carry information upward, from the gut to the brain. Your brain is mostly listening. Your gut is doing most of the talking.

The vagus nerve transmits information about:

• Gut microbial composition — changes in bacterial populations are detected and relayed to the brainstem
• Inflammatory status — cytokine levels and immune activation in the gut wall are communicated centrally
• Nutrient availability — the presence or absence of specific nutrients and metabolites triggers vagal signaling
• Mechanical distension — the physical state of your gut (how full, how much motility) is continuously monitored
• Microbial metabolites — short-chain fatty acids, tryptophan metabolites, and other bacterial byproducts activate vagal afferents

This isn’t metaphor. In a landmark 2011 study published in Proceedings of the National Academy of Sciences, researchers showed that the probiotic Lactobacillus rhamnosus (JB-1) reduced anxiety and depression-like behavior in mice — but only when the vagus nerve was intact. When the vagus nerve was surgically severed (vagotomy), the probiotic had zero effect on behavior. The bacteria were still in the gut. They were still producing metabolites. But without the vagus nerve to relay the signal, the brain never got the message.

This study is one of the clearest demonstrations that the gut-brain axis is not a vague concept — it is a specific, anatomically defined communication system with a known primary pathway.

Vagal Tone: The Fitness Metric You’re Not Tracking

Vagal tone refers to the activity level of the vagus nerve. Higher vagal tone correlates with better emotional regulation, lower resting heart rate, improved heart rate variability (HRV), reduced inflammation, and faster recovery from stress. It is measurable — HRV is a reliable proxy — and it is trainable.

People with low vagal tone tend to have:

• Higher baseline inflammation (elevated CRP, IL-6)
• Greater susceptibility to depression and anxiety
• Poorer gut motility and digestion
• Reduced capacity to return to calm after stress
• Weaker immune regulation

The connection to longevity is direct: chronic low-grade inflammation — often called “inflammaging” — is one of the hallmarks of biological aging. The vagus nerve’s anti-inflammatory pathway (the “cholinergic anti-inflammatory pathway”) is one of the body’s primary mechanisms for keeping inflammation in check. A gut that is inflamed sends alarm signals up the vagus nerve; a healthy gut sends calming ones. Over decades, this difference compounds.

Your Gut as a Neurotransmitter Factory

The most paradigm-shifting discovery in modern neuroscience may be this: your gut bacteria are prolific manufacturers of the very same chemicals your brain uses to think, feel, and function. This isn’t a loose analogy. Gut microbes produce, modulate, or regulate the precursors to virtually every major neurotransmitter.

Serotonin: The Mood Molecule

We covered this extensively in our dedicated gut-serotonin article, but the key facts bear repeating in context: approximately 90–95% of the body’s total serotonin is produced in the gut by enterochromaffin cells (EC cells). These cells are directly influenced by gut bacteria — specific species like Clostridium sporogenes, Candida species, and Enterococcus produce metabolites that stimulate EC cells to synthesize serotonin from the amino acid tryptophan.

Gut serotonin does not cross the blood-brain barrier directly. Its influence on mood operates through the vagus nerve, through regulation of tryptophan availability for brain serotonin synthesis, and through modulation of inflammatory pathways that affect brain function. The mechanism is indirect but powerful.

GABA: The Calm Chemical

Gamma-aminobutyric acid (GABA) is the brain’s primary inhibitory neurotransmitter — it’s the chemical signal that tells neurons to slow down, stop firing, and relax. Low GABA activity is associated with anxiety, insomnia, chronic stress, and seizure disorders. It is the target of benzodiazepines (Xanax, Valium) and many sleep medications.

Multiple gut bacterial species produce GABA directly:

A 2019 study in Nature Microbiology analyzed over 1,000 gut microbiome samples and found that the abundance of GABA-producing bacteria correlated significantly with self-reported quality of life indicators and inversely with depression diagnosis. The researchers concluded that the microbiome’s capacity for neuroactive compound production is a “previously unrecognized dimension” of mental health.

Dopamine: The Drive Signal

Dopamine is the neurotransmitter of motivation, reward, focus, and motor control. It’s what makes you want to do things. Low dopamine function is implicated in depression, ADHD, Parkinson’s disease, and the modern epidemic of motivational deficit.

Approximately 50% of the body’s dopamine is produced in the gut. Specific bacterial species — including Bacillus and Serratia — synthesize dopamine or its direct precursor L-DOPA. Others, like Prevotella and Bacteroides, influence the tyrosine-dopamine pathway.

Like gut serotonin, gut dopamine doesn’t cross the blood-brain barrier directly. But gut-derived dopamine influences brain dopaminergic function through vagal signaling and through regulation of systemic inflammation — neuroinflammation being a well-documented suppressor of dopamine synthesis in the brain.

Other Neuroactive Compounds

The gut microbiome also produces or modulates:

• Norepinephrine — produced by Bacillus, Escherichia, and Saccharomyces species; involved in alertness and stress response
• Acetylcholine — produced by Lactobacillus species; involved in memory and learning
• Short-chain fatty acids (SCFAs) — butyrate, propionate, and acetate; produced when gut bacteria ferment dietary fiber; butyrate in particular is neuroprotective and anti-inflammatory
• Brain-derived neurotrophic factor (BDNF) — not produced by bacteria directly, but SCFA production increases BDNF expression in the brain; BDNF is critical for neuroplasticity and memory

The Microbiome-Inflammation-Brain Connection

If neurotransmitter production is the gut-brain axis’s most dramatic feature, inflammation is its most consequential. The link between gut health, systemic inflammation, and brain function is arguably the single most important pathway in the entire axis — and it explains why gut problems so often manifest as brain problems.

How It Works

A healthy gut microbiome maintains intestinal barrier integrity (the “tight junctions” between intestinal epithelial cells) and keeps the immune system calibrated — responsive to threats but not chronically activated. When the microbiome is disrupted (by antibiotics, poor diet, chronic stress, or infection), two things happen:

1. Barrier degradation: Tight junctions loosen, allowing bacterial fragments (lipopolysaccharides, or LPS) and other inflammatory molecules to enter the bloodstream
2. Immune dysregulation: The gut-associated lymphoid tissue (GALT), which contains 70–80% of the body’s immune cells, shifts toward pro-inflammatory signaling

The result is a measurable increase in circulating inflammatory markers — particularly TNF-α, IL-6, IL-1β, and C-reactive protein (CRP). These inflammatory molecules cross the blood-brain barrier (which itself becomes more permeable under chronic inflammatory conditions) and activate brain immune cells called microglia.

Activated microglia produce their own inflammatory cascade within the brain. This is neuroinflammation — and its effects are well-characterized:

• Reduced serotonin, dopamine, and BDNF synthesis in the brain
• Diversion of tryptophan from the serotonin pathway to the kynurenine pathway (producing neurotoxic quinolinic acid)
• Impaired hippocampal neurogenesis (new brain cell formation)
• Degradation of synaptic plasticity (the brain’s ability to form new connections)
• Cognitive impairment — brain fog, poor concentration, memory deficits
• Increased vulnerability to depression, anxiety, and neurodegeneration

This is not speculative. A 2020 meta-analysis in JAMA Psychiatry confirmed that patients with major depressive disorder have significantly elevated inflammatory markers compared to healthy controls. Multiple studies have shown that reducing peripheral inflammation (including gut-derived inflammation) improves depressive symptoms — sometimes as effectively as antidepressant medication.

Leaky Gut and Neuroinflammation: The Mechanism That Connects Everything

“Leaky gut” has been a contentious term — used loosely in wellness circles and dismissed by some gastroenterologists as non-specific. The scientific reality is more nuanced: increased intestinal permeability is a real, measurable phenomenon with documented consequences. The mechanism is well-understood and the connection to brain health is increasingly well-established.

What Intestinal Permeability Actually Means

The intestinal lining is a single cell layer thick. Cells are held together by protein complexes called tight junctions (primarily occludin, claudins, and zonula occludens proteins). In a healthy gut, these junctions allow nutrient absorption while preventing bacteria, bacterial fragments, and large molecules from entering the bloodstream.

When tight junctions are disrupted, the barrier becomes more permeable. The primary disruptors include:

• Gut dysbiosis — loss of barrier-protective species (especially butyrate-producers like Faecalibacterium prausnitzii and Roseburia)
• Chronic stress — cortisol directly increases intestinal permeability via the HPA axis
• NSAIDs — ibuprofen, aspirin, and naproxen directly damage the mucosal lining
• Alcohol — even moderate consumption increases gut permeability acutely
• Ultra-processed foods — emulsifiers (polysorbate 80, carboxymethylcellulose) directly erode the mucus layer
• Glyphosate exposure — emerging evidence suggests damage to tight junction proteins
• Zonulin — a protein that regulates tight junctions; elevated in celiac disease and non-celiac gluten sensitivity

The LPS → Neuroinflammation Cascade

When the gut barrier is compromised, lipopolysaccharide (LPS) — a component of gram-negative bacterial cell walls — enters the bloodstream. This condition is called metabolic endotoxemia. Even low-level LPS in circulation triggers a systemic immune response:

1. LPS binds to TLR4 receptors on immune cells → triggers NF-κB inflammatory pathway
2. Pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) flood the circulation
3. Cytokines cross the blood-brain barrier (or signal through it via transport mechanisms)
4. Brain microglia activate → local neuroinflammation
5. Tryptophan diverts to kynurenine pathway → less serotonin, more neurotoxic quinolinic acid
6. Dopamine synthesis suppressed → reduced motivation, focus, reward sensitivity
7. BDNF expression drops → impaired neuroplasticity, accelerated brain aging

This cascade — gut barrier damage → endotoxemia → systemic inflammation → neuroinflammation → neurotransmitter depletion → cognitive and mood decline — is one of the most important pathological pathways in modern health. It connects a bad diet to depression. It connects chronic stress to brain fog. And it connects gut health to how fast your brain ages.

BPC-157 and Gut Healing: Where Peptide Science Meets the Axis

If the gut-brain axis depends on barrier integrity, and barrier integrity depends on gut healing capacity, then compounds that accelerate gut tissue repair become directly relevant to brain health. This is where BPC-157 enters the conversation.

We’ve written a comprehensive breakdown of BPC-157’s research evidence. The short version: BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein in human gastric juice. It has an extensive preclinical (animal model) track record for gut healing, but no published human clinical trials. It is not FDA-approved.

Why BPC-157 Is Relevant to the Gut-Brain Axis

In animal models, BPC-157 has demonstrated:

• Accelerated gastric ulcer healing — the most replicated finding across multiple studies
• Reduced NSAID-induced gut damage — directly relevant to the barrier-disruption pathway described above
• Anti-inflammatory effects via NF-κB modulation — the same pathway that drives LPS-mediated neuroinflammation
• Promotion of angiogenesis — new blood vessel formation in damaged tissue, supporting repair
• Protection against experimental colitis — reduced inflammatory markers and improved tissue histology in IBD models
• Neuroprotective effects — separate from gut healing, BPC-157 has shown protective effects in models of traumatic brain injury and dopaminergic damage

The theoretical case for BPC-157 in the gut-brain axis framework is coherent: if gut barrier damage drives neuroinflammation, and BPC-157 accelerates gut tissue repair while simultaneously modulating NF-κB inflammatory signaling, then it could address multiple nodes of the gut-brain disruption cascade.

Other Gut-Healing Peptides Worth Knowing

BPC-157 isn’t the only peptide relevant to gut barrier repair. KPV is a tripeptide (α-MSH fragment) that modulates the NF-κB pathway and has shown anti-inflammatory effects in experimental colitis models. We’ve covered it in our KPV deep dive. Like BPC-157, KPV is an investigational compound without FDA approval or completed human trials.

Probiotics vs Prebiotics vs Postbiotics: What Actually Works

This is where the gut-brain axis conversation often collapses into marketing. “Probiotic” has become a $70 billion industry catchphrase applied to everything from yogurt to gummy bears. Most of it is noise. Here’s the signal.

Probiotics: Live Bacteria (When They Actually Survive)

A probiotic is a live microorganism that, when administered in adequate amounts, confers a health benefit on the host. The key word is “adequate.” Most commercial probiotics face three problems:

1. Survival: Many strains don’t survive stomach acid. If the bacteria are dead by the time they reach the colon, the CFU count on the label is irrelevant.
2. Colonization: Most supplemental probiotics are transient — they pass through without establishing permanent residence. This isn’t necessarily bad (transient bacteria still produce metabolites), but it means the effects stop when you stop taking them.
3. Strain specificity: Benefits are strain-specific, not genus-specific. “Lactobacillus” is not a useful label. Lactobacillus rhamnosus GG (LGG) has a different evidence base than Lactobacillus acidophilus NCFM. A probiotic that doesn’t list specific strains is not a serious product.

Strains with the strongest evidence for gut-brain benefits:

Prebiotics: Feeding the Good Bacteria

Prebiotics are non-digestible fibers that selectively feed beneficial gut bacteria. Unlike probiotics, they don’t introduce new organisms — they support the growth of what’s already there. In many cases, prebiotics may be more impactful than probiotics because they address the root issue: creating an environment where beneficial bacteria can thrive.

Key prebiotics with gut-brain relevance:

• Galactooligosaccharides (GOS): A 2015 study in Psychopharmacology showed that 3 weeks of GOS supplementation reduced cortisol awakening response and shifted attention away from negative stimuli in healthy volunteers — effects comparable to anxiolytic medication
• Fructooligosaccharides (FOS): Selectively feeds Bifidobacterium species; increases SCFA production; supports barrier function
• Resistant starch: Found in cooked-then-cooled potatoes, green bananas, and legumes; one of the most potent butyrate-generating substrates
• Inulin: Found in chicory root, garlic, onions, and artichokes; feeds multiple beneficial genera
• Partially hydrolyzed guar gum (PHGG): Well-tolerated prebiotic with strong evidence for IBS symptom reduction

Postbiotics: The Metabolite Revolution

Postbiotics are the newest category and potentially the most important. They are the bioactive metabolites and cell fragments produced by gut bacteria — the actual molecules that do the work. The logic is simple: if probiotics are valuable primarily because of what they produce, why not supplement the products directly?

Key postbiotics:

• Butyrate: The most studied postbiotic. A short-chain fatty acid that fuels colonocytes (colon cells), strengthens tight junctions, reduces inflammation, increases BDNF expression in the brain, and inhibits histone deacetylases (epigenetic anti-aging effect). Available as tributyrin (a more stable supplemental form).
• Urolithin A: Produced from ellagic acid (found in pomegranates and walnuts) by specific gut bacteria. Promotes mitophagy (clearing damaged mitochondria). The longevity compound Mitopure is a direct urolithin A supplement for people whose microbiome doesn’t produce enough.
• Akkermansia muciniphila metabolites: A. muciniphila is a keystone species for gut barrier health. Its metabolites strengthen the mucus layer. The company Pendulum sells a pasteurized Akkermansia product that has shown metabolic benefits in RCTs.

Fermented Foods vs Supplements: An Honest Comparison

The fermented food vs. probiotic supplement debate is one of the few areas in gut health where we have a clear, evidence-based winner — at least for general microbiome diversity.

A 2021 Stanford study published in Cell compared a high-fiber diet to a high-fermented-food diet over 10 weeks. The results were striking:

• The fermented food group showed significantly increased microbiome diversity and reduced inflammatory markers (including IL-6, IL-10, and IL-18)
• The high-fiber group did not increase diversity over the study period (though fiber is still essential for maintaining existing diversity)
• The more servings of fermented food per day (target: 6+ servings), the greater the diversity increase

This doesn’t mean supplements are useless — it means they solve a different problem. Fermented foods introduce a diverse ecosystem. Specific probiotic strains address specific conditions.

Top fermented foods for gut-brain health: sauerkraut (unpasteurized), kimchi, kefir (dairy or water), full-fat plain yogurt with live cultures, miso, natto, tempeh, and kombucha (watch the sugar content).

The Psychobiome Concept

The term “psychobiome” was coined to describe the subset of the gut microbiome that specifically influences psychological function — the organisms and metabolic pathways that shape mood, cognition, stress resilience, and behavior. It’s a refinement of the broader gut-brain axis concept, focusing specifically on the microbial actors with documented neurological effects.

The psychobiome framework has shifted the conversation in psychiatry. Instead of viewing depression, anxiety, and cognitive decline as purely brain disorders, researchers are now investigating them as systemic conditions with significant gut-microbial components.

Key Findings in Psychobiome Research

• Germ-free mice (raised without any gut bacteria) show dramatically altered stress responses, anxiety behaviors, and social behaviors compared to conventionally colonized mice. These changes are partially reversible if bacteria are introduced early in life — but not if introduced later, suggesting a critical developmental window.
• Fecal microbiota transplant (FMT) studies have shown that transferring stool from depressed humans to germ-free mice induces depressive behaviors in the mice. This is some of the strongest evidence that the microbiome can causally influence mood.
• The “missing microbes” hypothesis: People with depression consistently show reduced microbial diversity and depletion of specific genera — particularly Coprococcus, Dialister, Faecalibacterium, and Bifidobacterium. Whether this is cause or consequence remains an active area of research, but FMT studies suggest at least partial causality.
• Birth mode and early colonization: Vaginal delivery vs. C-section, breastfeeding vs. formula, and early antibiotic exposure all significantly shape the psychobiome. The long-term mental health implications of early microbial disruption are increasingly recognized.

The psychobiome is not a separate entity from the microbiome — it’s a lens. The same bacteria that regulate inflammation, produce SCFAs, and maintain barrier integrity are often the same bacteria that produce neuroactive compounds. Gut health and mental health are not correlated. They are mechanistically linked.

How GLP-1 Drugs Affect Your Gut Health

GLP-1 receptor agonists — semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and the emerging retatrutide — are the most significant pharmacological development in metabolic medicine in decades. Their effects on weight loss and metabolic health are well-documented. Their effects on the gut microbiome are only beginning to be understood.

What the Early Research Shows

GLP-1 (glucagon-like peptide-1) is a hormone produced primarily by L-cells in the small intestine. It signals satiety to the brain, slows gastric emptying, and stimulates insulin secretion. GLP-1 receptor agonists mimic and amplify this natural hormone’s effects.

Because GLP-1 is fundamentally a gut hormone, the drugs that mimic it have widespread effects on gut physiology:

• Delayed gastric emptying: This is the mechanism behind the “food noise” reduction users report. But it also changes the transit time of food through the gut, which alters microbial fermentation patterns and SCFA production.
• Altered bile acid metabolism: GLP-1 agonists affect bile acid signaling, which in turn affects the gut microbiome (bile acids are a major selective pressure on microbial populations).
• Reduced inflammation: Multiple studies show GLP-1 agonists reduce systemic inflammatory markers — including gut-derived inflammation. This is a potential gut-brain axis benefit.
• Microbiome composition shifts: A 2023 study in Gut Microbes found that semaglutide treatment was associated with increased abundance of Akkermansia muciniphila and decreased Firmicutes/Bacteroidetes ratio — changes generally associated with improved metabolic health.

The GI Side Effects Question

The most common side effects of GLP-1 drugs are gastrointestinal: nausea, vomiting, diarrhea, constipation. These are typically attributed to delayed gastric emptying and direct gut receptor stimulation. But there’s a question the research hasn’t fully answered: are GLP-1 drugs also reshaping the microbiome in ways that contribute to GI symptoms, or in ways that might have longer-term gut health implications?

The honest answer is: we don’t know yet. The data on GLP-1 agonists and the microbiome is early-stage. What we can say is that any drug that fundamentally changes gut motility, bile acid signaling, and dietary intake patterns will inevitably alter the microbiome — and those changes will ripple through the gut-brain axis.

For more on GLP-1 drugs, see our guides on semaglutide, tirzepatide, and retatrutide.

Gut Health Protocols from Longevity Researchers

Several of the most prominent figures in longevity research have emphasized gut health as a foundational pillar. Here’s what the leading researchers and clinicians are actually recommending — stripped of marketing:

Peter Attia, MD (Outlive)

Attia emphasizes gut health primarily through fiber diversity and metabolic health. His framework centers on zone 2 exercise (which improves gut motility and microbial diversity), time-restricted eating (which allows for the migrating motor complex — the gut’s “cleaning wave” — to function), and elimination of ultra-processed foods that disrupt the mucosal layer.

Andrew Huberman, PhD (Huberman Lab)

Huberman has emphasized fermented foods (1–4 servings daily), prebiotic fiber diversity (aiming for 30+ plant types per week), and the importance of the gut-brain vagal connection. He frequently cites the 2021 Stanford fermented foods study and recommends low-sugar fermented options like sauerkraut and kimchi over kombucha.

Rhonda Patrick, PhD (FoundMyFitness)

Patrick’s work has focused extensively on sulforaphane (from broccoli sprouts), which has been shown to modulate the NF-κB pathway and support gut barrier integrity. She also emphasizes omega-3 fatty acids for their anti-inflammatory effects on the gut lining and the importance of Akkermansia muciniphila as a keystone species for gut barrier health.

The Emerging Consensus Protocol

Across these and other longevity-focused researchers, a protocol consensus is emerging:

1. Fiber diversity first: 30+ different plant foods per week (not just volume — diversity is what drives microbial diversity)
2. Daily fermented foods: 2–6 servings of unpasteurized fermented foods
3. Eliminate emulsifiers: Polysorbate 80, carboxymethylcellulose, and other emulsifiers found in processed foods directly damage the mucus layer
4. Protect the migrating motor complex: Allow 4–5 hour gaps between meals; constant snacking suppresses the gut’s self-cleaning mechanism
5. Move daily: Regular exercise (especially zone 2) improves gut motility and microbial diversity independently of diet
6. Manage cortisol: Chronic stress increases gut permeability; stress management is a gut health intervention
7. Consider targeted supplementation: Butyrate (tributyrin), specific probiotic strains based on testing, and omega-3s for anti-inflammatory support

Gut Testing: What’s Worth Your Money

The gut testing market has exploded, with companies offering microbiome analysis ranging from $100 to $500+. Here’s an honest assessment of what’s available and what’s actually useful.

Our recommendation: If you’re dealing with specific GI symptoms, start with a GI-MAP through a functional medicine practitioner. For general optimization, a shotgun metagenomics test (companies like Viome, Thorne Gut Health, or biomesight offer these) gives you the most actionable data about your microbiome’s functional capacity.

Practical Protocol: Optimizing Your Gut-Brain Connection

Based on the research covered in this article, here is a structured protocol for optimizing gut-brain axis function. This is not medical advice — it’s a synthesis of the evidence into an actionable framework. Modify based on individual needs, existing conditions, and guidance from your healthcare provider.

Phase 1: Foundation (Weeks 1–4)

Phase 2: Build (Weeks 5–8)

Phase 3: Optimize (Weeks 9–12+)

Products Worth Considering (Affiliate Recommendations)

Based on the evidence reviewed in this article, these are products we’ve researched and consider worth evaluating. Individual needs vary — what works depends on your baseline gut health, symptoms, and goals.

Probiotic Supplements

• Seed DS-01 Daily Synbiotic: Contains 24 clinically studied strains including L. rhamnosus GG and B. longum subsp. infantis. Uses a patented capsule-in-capsule technology (ViaCap) designed to survive stomach acid. One of the few products with published third-party viability testing.
• Pendulum Akkermansia: The only commercially available Akkermansia muciniphila product. Pasteurized form with RCT data for metabolic health. Relevant for gut barrier support.
• Visbiome (formerly VSL#3): High-dose multi-strain probiotic with clinical evidence for IBS and ulcerative colitis. Contains 450 billion CFU per packet.

Postbiotic / Gut Health Supplements

• Tributyrin (BodyBio Butyrate, CoreBiome Tributyrin): Supplemental butyrate in its most bioavailable form. Supports colonocyte health, tight junction integrity, and anti-inflammatory signaling.
• Mitopure (Timeline Nutrition): Direct urolithin A supplementation. Addresses the fact that most people’s microbiomes don’t efficiently convert ellagic acid to urolithin A. Longevity-relevant.

Gut Testing Kits

• Viome Full Body Intelligence: Combines gut microbiome analysis with oral and cellular health testing. Uses metatranscriptomic (RNA) analysis for functional insights.
• Thorne Gut Health Test: Shotgun metagenomics with good actionable reporting. Identifies species-level composition and functional pathways.
• Diagnostic Solutions GI-MAP: Clinical-grade qPCR test for pathogens, parasites, and inflammatory markers. Requires practitioner ordering in most cases.

Fermented Food Starters

• Cultures for Health starter kits: Kefir grains, yogurt starters, and vegetable fermentation kits. Homemade fermented foods are more diverse and more cost-effective than any supplement.

Frequently Asked Questions